The rate of buprenorphine use to treat opioid use disorder more than doubled between 2009 and 2018, ...
People who are treated with buprenorphine for more than 15 months appear to have superior clinical o...
Patients seeking treatment for heroin use in areas of the United States hardest hit by the opioid ep...
There are stark racial and economic divides in access to treatment for opioid use disorder (OUD): In...
The Food and Drug Administration (FDA) yesterday cleared for marketing a prescription smartphone app...
Naltrexone is a proven treatment for opioid use disorder (OUD), but its clinical usefulness, when ta...
A bipartisan legislative package passed yesterday by Congress takes many important steps toward comb...
Several medications approved to treat alcohol and opioid use disorders also appear to reduce suicida...
The Food and Drug Administration (FDA) has approved Sublocade, the first once-monthly injectable bup...
